Edap Tms SANASDAQ:EDAP
- LAST PRICE7.0900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.8600/ 1
- Ask / Lots11.2700/ 1
- Open / Previous Close0.0000 / 7.0900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EDAP |
|---|---|---|
| 09:32 ET | 4136 | 7.09 |
| 09:41 ET | 588 | 7.12 |
| 09:45 ET | 100 | 7.13 |
| 09:48 ET | 2772 | 7.12 |
| 09:52 ET | 100 | 7.09 |
| 09:54 ET | 2097 | 7.15 |
| 10:08 ET | 700 | 7.12 |
| 10:10 ET | 200 | 7.12 |
| 10:12 ET | 100 | 7.12 |
| 10:14 ET | 100 | 7.12 |
| 10:17 ET | 200 | 7.12 |
| 11:24 ET | 100 | 7.12 |
| 11:27 ET | 100 | 7.165 |
| 12:16 ET | 100 | 7.14 |
| 12:34 ET | 100 | 7.12 |
| 01:37 ET | 200 | 7.14 |
| 03:50 ET | 1000 | 7.09 |
| 03:52 ET | 100 | 7.11 |
| 03:57 ET | 854 | 7.09 |
Yesterday
Apr 1, 2024
DJ EDAP TMS Is Maintained at Buy by HC Wainwright & Co., from 7:02AM ET on Monday Apr 01, 2024 by Dow Jones
7:02AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 27, 2024
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results, from 7:00AM ET on Wednesday Mar 27, 2024 by Dow Jones
7:00AM ET on Wednesday Mar 27, 2024 by Dow Jones*DJ EDAP TMS 4Q Rev EUR19.6M >EDAP, from 7:00AM ET on Wednesday Mar 27, 2024 by Dow Jones
7:00AM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Edap Tms SA | 263.1M | -11.6x | --- |
Neuropace Inc | 397.1M | -10.9x | --- |
Butterfly Network Inc | 154.4M | -1.1x | --- |
Neuronetics Inc | 115.7M | -3.7x | --- |
908 Devices Inc. | 183.0M | -4.9x | --- |
Akoya Biosciences Inc | 187.2M | -2.6x | --- |
Company Information
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Contact Information
- Headquarters
- Parc Activite La Poudrette LamartineVAULX-EN-VELIN, France 69120
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Marc Oczachowski
- Chief Executive Officer
- Ryan Rhodes
- Global Chief Financial Officer
- Ken Mobeck
- Global Chief Accounting Officer
- Francois Dietsch
- Independent Director
- Pierre Beysson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $263.1M |
|---|---|
Revenue (TTM) | $64.6M |
Shares Outstanding | 37.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-0.61 |
Book Value | $1.64 |
P/E Ratio | -11.6x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -32.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
